For ATXN2, intermediate expansions (29–33 repeats) are associated with ALS risk while expansions > 33 repeats cause spinocerebellar ataxia type 2 (SCA2), a neurodegenerative disease which primarily affects cerebellar Purkinje neurons [6]. Here, ATXN2 is linked to amyotrophic lateral sclerosis.